Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection
| Image |  |
|---|---|
| Description | scientific article published on 14 October 2019 |
| Author/s |
author: Makoto Nakamuta Kojiro Michitaka Etsuko Iio Tsunamasa Watanabe Noritomo Shimada Akemi Tsutsui Shinichi Fujioka Naoki Yamashita Toru Asano Takehiro Akahane Hidenori Toyoda Joji Tani Hiroki Ikeda Katsuhiko Iwakiri Atsushi Hiraoka Tsutomu Masaki Koichi Takaguchi Toshihide Shima Asahiro Morishita Makoto Chuma Toru Ishikawa Haruki Uojima Masanori Atsukawa Akihito Tsubota Takuya Genda Yoshihiko Tachi Hironao Okubo Yasuhito Tanaka Akito Nozaki Shinya Fukunishi Takashi Kumada |
| Publication date | October 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |